Recent Press Releases Apr 20, 2026 Annals of Internal Medicine Publishes 12-Month Results from LivaNova’s OSPREY Clinical Study for Obstructive Sleep Apnea Mar 25, 2026 LivaNova to Announce First-Quarter 2026 Results Mar 19, 2026 LivaNova Receives U.S. Food and Drug Administration Premarket Approval for aura6000 System to treat Moderate to Severe Obstructive Sleep Apnea Feb 25, 2026 LivaNova Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Guidance View All News Releases View All News Upcoming Events May 6, 2026 8:00 AM EDT 1Q 2026 LivaNova PLC Earnings Conference Call View All Events View All Events
